Luis Pena reports a stock award at Evommune
By AlphaYouPublished Form 4
Pena Luis C.
Reporting filer
Luis Pena reports a stock award, not an open-market purchase or sale, in Evommune, Inc.. Form 4 filed Oct 15, 2026 lists 1 entry.
- Disclosed
- Oct 15, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Pena Luis C. | 2026-09-30 | A | Grant or award | 1115.00 | 7.02 | 631,573 | 15 days | Filed terms
|
Common Stock
- Owner
- Pena Luis C.
- Date
- 2026-09-30
- Code
- A
- Action
- Grant or award
- Quantity
- 1115.00
- Price
- 7.02
- Following holdings
- 631,573
- Reporting delay
- 15 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Timeliness:
- transaction Shares: 1115.00
- id: F1
- transaction Price Per Share: 7.02
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 631573.00
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Pena Luis C.: President & CEO, Director.
- F1: Represents shares acquired under the non-qualified component of the Evommune, Inc. 2025 Employee Stock Purchase Plan ("ESPP").
- F2: In accordance with current ESPP offering standards, these shares were purchased at 85% of the closing price of the Issuer's common stock on September 30, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.